Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor. (2023)
Attributed to:
SMARTCell: Scalable Manufacture of Advanced Regenerative Therapeutics - Cell Therapies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2023.06.011
PubMed Identifier: 37528866
Publication URI: http://europepmc.org/abstract/MED/37528866
Type: Journal Article/Review
Volume: 30
Parent Publication: Molecular therapy. Methods & clinical development
ISSN: 2329-0501